A 51-year-old hemodialysis patient was admitted for methicillin-sensitive *Staphylococcus aureus* (MSSA) bacteremia from an unknown primary focus. A transthoracic echocardiogram showed no cardiac vegetation. ^18^F-fludeoxyglucose positron emission tomography (18F-FDG PET) revealed an increased uptake in the aortic arch ([Picture 1](#g001){ref-type="fig"}, white arrow) with a maximum standard uptake value of 5.30. Both atherosclerosis and inflammation were considered. The patient completed 4 weeks of effective antibiotic treatment, but recurrent MSSA bacteremia developed again 2 months later. Transesophageal echocardiography to rule out infective endocarditis revealed no vegetation, but a pseudoaneurysm was identified at the aortic arch. Computed tomography angiography (CTA) was done 2 months after the PET study and disclosed the presence of a 3.4 cm aortic aneurysm with periaortic fluid, which was compatible with a mycotic aneurysm ([Picture 2](#g002){ref-type="fig"}, white arrow). A mycotic aneurysm in the aortic arch is a rare, but life-threatening development ([@B1]). 18F-FDG PET is sensitive and reproducible for delineating vascular inflammation (e.g., vasculitis and atherosclerosis) ([@B2]), and it can also detect infected aortic aneurysms. It may be useful to identify the presence of a mycotic aneurysm in the aortic arch, especially in hemodialysis patients.
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